China and the US Find Common Ground on the Application of Artificial Intelligence in Healthcare
Read more
CGTN
cgtn.com

China and the US Find Common Ground on the Application of Artificial Intelligence in Healthcare

Artificial intelligence is gradually moving from laboratories into hospitals, clinics, and people's daily lives; however, transforming technological breakthroughs into reliable medical services remains a complex challenge. At the China International Fair for Trade in Services (CIFTIS) in Beijing in 2026, topics related to AI-based healthcare and elderly care were actively discussed.

Technologies such as AI-based health management platforms and intelligent nurse robots are already being used to reduce the burden caused by nursing staff shortages and improve services for the older generation. Nevertheless, industry representatives also pointed out persistent difficulties.

As medical AI rapidly develops globally, the overarching issue is the gap between AI's technical capabilities and what can be safely and effectively implemented in healthcare. International cooperation can bridge this gap by combining technological expertise, clinical experience, investment, funding, and practical application scenarios.

From Healthcare Dialogue to AI Cooperation

China and the United States have a long history of dialogue and interaction in the healthcare sector. Recently, artificial intelligence has become an increasingly prominent part of these discussions. At the 11th China-US Health Dialogue held in Hangzhou in June, experts from both countries examined biomedical innovations, implementation science, the application of AI in healthcare systems, and cardiovascular disease prevention.

Participants also explored avenues for closer partnership, including the use of digital health and AI to improve chronic disease management. The significance of this discussion reflects a broader shift in medicine: technology is increasingly being applied not only for diagnosing and treating diseases but also for assisting people with health monitoring, managing chronic conditions, and making more informed decisions in daily life.

Cooperation is Already Taking Shape

In November 2025, GE HealthCare and Damo Academy (Alibaba) signed a framework agreement. The parties announced their intention to combine GE HealthCare's expertise in medical imaging with Damo Academy's AI capabilities to develop comprehensive solutions that ensure more accurate and effective diagnostics.

This collaboration focuses on integrating AI with non-contrast CT scans to detect various types of cancer, acute conditions, and chronic diseases. Furthermore, both sides plan to work on optimizing models and developing products to transfer AI technologies from the research stage to clinical application.

As China and the United States continue to explore how AI can transform healthcare—from medical imaging and chronic disease management to preventive care and daily medical services—their priorities are increasingly aligning in the same areas. This opens opportunities for the two countries to combine their strengths in technology, medical experience, investment, and practical application to translate AI advancements into more accessible and actionable medical services.

The future of AI in healthcare will be determined not only by who develops the most advanced technologies but also by how effectively these technologies can be realized as safe, accessible, and beneficial care. For China and the United States, continued dialogue and practical cooperation may be the path to turning their parallel achievements in AI and healthcare into solutions that benefit patients and healthcare systems on both sides.

Similar stories

RAND Corporation study reveals differences in AI development in the US and China: 61% of American firms are software, versus 26% in China
Read more
cgtn.com

RAND Corporation study reveals differences in AI development in the US and China: 61% of American firms are software, versus 26% in China

The differences in artificial intelligence (AI) development between the US and China were measured, not assumed. In August, the RAND Corporation center focusing on AI, security, and technology published a detailed count of companies in both countries, based on what each firm creates, sells, and patents. A total of 1181 companies were identified, with 743 based in America and 438 in China.

The main finding of the study is as follows: sixty-one percent of American AI companies specialize exclusively in software. In contrast, only twenty-six percent of Chinese firms fall into this category. The remaining companies in China are actively involved in creating physical carriers for their algorithms, including robots, vehicles, and drones.

Despite this key difference, RAND researchers found that the two industries are very similar in most aspects. Approximately 28% of American and 27% of Chinese firms use transformer architecture, which is the basis for systems like ChatGPT and DeepSeek. Furthermore, about nine out of ten American AI companies and three out of four Chinese ones sell ready-made products using AI—such as diagnostic tools or logistics control panels—instead of providing direct access to raw models.

Even the so-called 'AI arms race' between leading labs turned out to be a localized phenomenon: only about 19% of companies in each country are developers of foundational models that train general models from scratch, similar to how OpenAI or Alibaba do. Most of the other companies quietly develop software for hospitals, factories, and insurance companies.

The deep divergence between the two markets manifests in the application of their AI. Chinese firms focus on the manufacturing sector, transportation, and energy—that is, the physical economy. American companies, however, concentrate on healthcare, scientific research, and cybersecurity—which corresponds to the knowledge economy. Moreover, the share of companies dealing with humanoid robots in the Chinese sample is more than five times higher than in America: 12% of Chinese AI firms versus only 2% of American ones. At the same time, America produces significantly more startups specializing in diagnostic software.

The reasons for this division can be explained by the theory of division of labor proposed by the Scottish economist and philosopher Adam Smith. Since China maintains the world's densest production supply chain—including motors, batteries, actuators, and sensors—its AI naturally integrates into machinery. Moreover, there is state industrial policy that clearly points in this direction: in 2025, China declared 'embodied intelligence' a national priority and subsequently published a national standard system for humanoid robots.

Additionally, over half of China's AI companies in the RAND sample are part of large conglomerates such as Alibaba and Tencent, which provides them with an existing production base or fleet for implementing developments. America's advantage works in reverse. Its capital markets can invest tens of billions of dollars in a single language model hoping for a breakthrough, taking on this risk not the government, but Wall Street. America's deep experience in medicine, science, and security provides rich, high-value tasks for software AI to solve. This can be seen as a comparative advantage updated for the algorithmic age: no one is smarter, they simply specialize in what their own economy offers.

There is another quiet race running parallel to the story of robots versus chatbots—the battle over price. RAND tracked real developer traffic on OpenRouter, a gateway that directs API calls to hundreds of AI models. At the end of 2024, American models processed about nine-tenths of all traffic, while Chinese models were almost invisible. However, by April 2026, the situation had leveled out: the ratio became 49% to 47%. This shift was driven by open Chinese models, such as DeepSeek-V3 and the Qwen series, which achieve results close to the best American systems in independent benchmarks, while the overall cost per token is one-fourth or one-fifth the cost of American counterparts.

It is important to note that Chinese labs have not suddenly surpassed competitors at the highest level of intelligence; American systems still lead in raw intelligence metrics. Nevertheless, the principle of 'good enough, four times cheaper' represents the quiet, cumulative gain that changes the market from the bottom up, following the harsh logic that economist Joseph Schumpeter called 'creative destruction.'

These trends do not describe a sprint where one player wins. They demonstrate two nations solving different parts of the same problem, and it is in this gap that the most effective and economically viable opportunity for cooperation lies. These areas include testing the safety of humanoid robots when operating near people, creating common standards that allow a sensor created in Shenzhen to interact with software written in Seattle, and joint AI research for drug discovery and disease diagnosis.

Geoffrey Hinton, the 2024 Nobel laureate in Physics for creating the mathematical foundation of modern neural networks, stated directly that the technology is developing faster than most people expected, including himself, and that the risks are too great to manage solely through competition. This is an engineering fact.

The British mathematician and logician Alan Turing, writing in 1950, put it simply: 'We can see only a short distance ahead, but there is much to be done.' Seventy-five years later, one country taught its machines to speak and reason, while another taught them to walk and lift heavy objects. Ultimately, something will have to do both, and then the two parts of this story—mind and body—will finally meet.

Popular